Product Images Topiramate

The text describes cumulative rates for time to first seizure for two groups of people who were given different doses of Topiramate. The data is visualized through a graph with time in days on the x-axis and cumulative rates on the y-axis. The graph shows that the group that received 400mg/day had a lower rate of seizures compared to those who received 50mg/day. The statistical significance of this difference is noted as P=0.0002.*

This appears to be a table or a graph showing the change in migraine period rates for different groups of individuals receiving different doses of topiramate and a placebo during a double-blind phase. The values are accompanied by standard error (SE) and statistical significance indicated by asterisks. It is not clear what the significance levels represent or what the units of measurement are for the migraine period rates.*

This is a prescription drug information label for Topiramate tablets. The tablets are round and white, with the imprint "ZD;13" and are packaged in a container provided by Bryant Ranck Prepack Bunbauk. Each tablet contains 200mg Topiramate, and this drug is equivalent to Topamax 200mg Tablet. The storage temperature condition is between 20°-25°C (68°-77°F), and the drug should be kept in a tightly closed container. This label also provides the National Drug Code (NDC) number (7133511161) and the package expiration date (MM/YY).*